Literature DB >> 23893538

Lung cancer screening: state of the art.

Reginald F Munden1, Myrna C B Godoy.   

Abstract

Results from the National Lung Screening Trial have confirmed that lung cancer mortality is reduced using low-dose CT screening. Opening a lung cancer screening program requires a multidisciplinary approach. While the fundamental aspects of a screening program are similar, such as scheduling, performing, and managing follow-up, there are aspects of a lung cancer screening program that are unique. This article will discuss factors important in establishing a state of the art lung cancer screening program.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  LDCT; MDCT; low-dose CT; lung cancer; lung cancer screening; pulmonary nodule

Mesh:

Year:  2013        PMID: 23893538     DOI: 10.1002/jso.23388

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Cytotoxicity of glucoevatromonoside alone and in combination with chemotherapy drugs and their effects on Na+,K+-ATPase and ion channels on lung cancer cells.

Authors:  Naira Fernanda Zanchett Schneider; Danusa Menegaz; Andre Luiz Andreotti Dagostin; Lara Persich; Sayonarah C Rocha; Ana Carolina Pacheco Ramos; Vanessa Faria Cortes; Carlos Frederico Leite Fontes; Rodrigo Maia de Pádua; Jennifer Munkert; Wolfgang Kreis; Fernão Castro Braga; Leandro A Barbosa; Fátima Regina Mena Barreto Silva; Cláudia Maria Oliveira Simões
Journal:  Mol Cell Biochem       Date:  2021-01-18       Impact factor: 3.396

Review 2.  Lung cancer screening with low-dose computed tomography for primary care providers.

Authors:  Thomas B Richards; Mary C White; Ralph S Caraballo
Journal:  Prim Care       Date:  2014-03-26       Impact factor: 2.907

3.  Clinical application of CT and CT-guided percutaneous transthoracic needle biopsy in patients with indeterminate pulmonary nodules.

Authors:  Luciana Vargas Cardoso; Arthur Soares Souza Júnior
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

Review 4.  Epidemiology of lung cancer in China.

Authors:  Maomao Cao; Wanqing Chen
Journal:  Thorac Cancer       Date:  2018-11-28       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.